Risk Factors for Major Complications After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma

Annals of Thoracic Surgery

Volumn 85, Issue 4, 2008, Pages 1206-1210

  de Perrot, Marc ^a   McRae, Karen ^a   Anraku, Masaki ^a   Karkouti, Keyvan ^a   Waddell, Thomas K ^a   Pierre, Andrew F ^a   Darling, Gail ^a   Keshavjee, Shaf ^a   Johnston, Michael R ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; HEMOGLOBIN;

ABDOMINAL WALL HERNIA; ARTICLE; BRONCHOPLEURAL FISTULA; CANCER CHEMOTHERAPY; CHYLOTHORAX; DEATH; EMPYEMA; ERYTHROCYTE TRANSFUSION; ESOPHAGUS PERFORATION; EXTRAPLEURAL PNEUMONECTOMY; HEART ARREST; HEART ATRIUM FIBRILLATION; HEMATOTHORAX; HEMOGLOBIN BLOOD LEVEL; HIATUS HERNIA; HUMAN; LUNG EMBOLISM; LUNG INJURY; LUNG RESECTION; MULTIVARIATE ANALYSIS; PLEURA MESOTHELIOMA; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY;

ADULT; AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; CAUSE OF DEATH; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MESOTHELIOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PLEURA; PLEURAL NEOPLASMS; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION;

EID: 40749131212     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.11.065     Document Type: Article

References (24)

1. Robinson B.W.S., and Lake R.A. Advances in malignant mesothelioma. N Engl J Med 353 (2005) 1591-1603
2. Sugarbaker D.J., Jaklitsch M.T., Bueno R., et al. Prevention, early detection, anad management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 128 (2004) 138-146
3. Stewart D.J., Martin-Ucar A.E., Edwards J.G., West K., and Waller D.A. Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risk of induction chemotherapy, right-sided procedures and prolonged operations. Eur J Cardiothorac Surg 27 (2005) 373-378
4. Opitz I., Kestenholz P., Lardinois D., et al. Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma. Eur J Cardiothorac Surg 29 (2006) 579-584
5. de Perrot M., Uy K., Anraku M., et al. Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 133 (2007) 111-116
6. Flores R.M., Krug L.M., Rosenzweig K.E., et al. Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial. J Thorac Oncol 1 (2006) 289-295
7. Weder W., Kestenholz P., Taverna C., et al. Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. J Clin Oncol 22 (2004) 3451-3457
8. International Mesothelioma Interest Group. A proposed new international TNM staging system for malignant pleural mesothelioma. Chest 108 (1995) 1122-1128
9. Martin J., Ginsberg R.J., Abolhoda A., et al. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann Thorac Surg 72 (2001) 1149-1154
10. Darling G.E., Abdurahman A., Yi Q.L., et al. Risk of a right pneumonectomy: role of bronchopleural fistula. Ann Thorac Surg 79 (2005) 433-437
11. Karkouti K., O'Farrell R., Yau T.M., and Beattie W.S. Prediction of massive blood transfusion in cardiac surgery. Can J Anesth 53 (2006) 781-794
12. Karkouti K., Wijeysundera D.N., Yau T.M., et al. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion 44 (2004) 1453-1462
13. Thomas P., Michelet P., Barlesi F., et al. Impact of blood transfusions on outcome after pneumonectomy for thoracic malignancies. Eur Respir J 29 (2007) 565-570
14. Harpole D.H., DeCamp M.M., Daley J., Hur K., Oprian C.A., and Khuri S.F. Prognostic models of thirty-day mortality and morbidity after major pulmonary resection. J Thorac Cardiovasc Surg 117 (1999) 969-979
15. Spiess B.D., Tuman K.J., McCarthy R.J., DeLaria G.A., Schillo R., and Ivanovich A.D. Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies. J Clin Monit 3 (1987) 25-30
16. Kurata M., and Horii I. Blood coagulation tests in toxicological studies-review of methods and their significance for drug safety assessment. J Toxicol Sci 29 (2004) 13-32
17. Mangano D.T., Tudor I.C., and Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 354 (2006) 353-365
18. Wright J.R., Ung Y.C., Julian J.A., et al. Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia. J Clin Oncol 25 (2007) 1027-1032
19. Steinbrook R. Erythropoietin, the FDA, and oncology. N Engl J Med 356 (2007) 2448-2451
20. Nosotti M., Rebulla P., Riccardi D., et al. Correlation between perioperative blood transfusion and prognosis of patients subjected to surgery for stage I lung cancer. Chest 124 (2003) 102-107
21. Yovino S., Kwok Y., Krasna M., Bangalore M., and Suntharalingam M. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone. Int J Radiat Oncol Biol Phys 62 (2005) 1438-1443
22. Berardi R., Brunelli A., Tamburrano T., et al. Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for non-small cell lung cancers. Lung Cancer 49 (2005) 371-376
23. Ottonello L., Ghio M., Contini P., et al. Nonleukoreduced red blood cell transfusion induces a sustained inhibition of neutrophil chemotaxis by stimulating in vivo production of transforming growth factor-beta1 by neutrophils: role of the immunoglobulinlike transcript 1, sFasL, and sHLA-I. Transfusion 47 (2007) 1395-1404
24. Anraku M, Cunningham KS, Yun Z, et al. Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma. J Thorac Cardiovasc Surg. In press.